Acute myeloid leukemia (AML) is an aggressive blood cancer in children. Even with strong chemotherapy and bone marrow transplants, many children relapse, and relapse is often deadly. About one in four children in this high-risk group carries a mutation in a gene called WT1. These patients often respond poorly to treatment and relapse early, but we still do not fully understand why. WT1 normally helps guide healthy blood cell growth. When WT1 is damaged, our research shows that leukemia cells can “rewire” themselves to survive.

Icahn School of Medicine at Mount Sinai
21 Claremont Avenue
Apt 94
NEW YORK, NY 10029
United StatesPages
- 1
- 2


